- Home
- WKSP vs ATHA Comparison
WKSP vs ATHA Comparison
Compare WKSP & ATHA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WKSP
- ATHA
- Stock Information
- Founded
- WKSP 2003
- ATHA 2011
- Country
- WKSP United States
- ATHA United States
- Employees
- WKSP N/A
- ATHA N/A
- Industry
- WKSP Auto Parts:O.E.M.
- ATHA Medicinal Chemicals and Botanical Products
- Sector
- WKSP Consumer Discretionary
- ATHA Health Care
- Exchange
- WKSP Nasdaq
- ATHA Nasdaq
- Market Cap
- WKSP 14.6M
- ATHA 14.8M
- IPO Year
- WKSP N/A
- ATHA 2020
- Fundamental
- Price
- WKSP $3.06
- ATHA $0.38
- Analyst Decision
- WKSP Strong Buy
- ATHA Buy
- Analyst Count
- WKSP 3
- ATHA 4
- Target Price
- WKSP $12.83
- ATHA $11.25
- AVG Volume (30 Days)
- WKSP 331.4K
- ATHA 182.7K
- Earning Date
- WKSP 08-13-2025
- ATHA 08-07-2025
- Dividend Yield
- WKSP N/A
- ATHA N/A
- EPS Growth
- WKSP N/A
- ATHA N/A
- EPS
- WKSP N/A
- ATHA N/A
- Revenue
- WKSP $12,395,166.00
- ATHA N/A
- Revenue This Year
- WKSP $151.32
- ATHA N/A
- Revenue Next Year
- WKSP $74.19
- ATHA N/A
- P/E Ratio
- WKSP N/A
- ATHA N/A
- Revenue Growth
- WKSP 232.13
- ATHA N/A
- 52 Week Low
- WKSP $2.44
- ATHA $0.22
- 52 Week High
- WKSP $12.00
- ATHA $3.67
- Technical
- Relative Strength Index (RSI)
- WKSP 45.00
- ATHA 54.38
- Support Level
- WKSP $3.12
- ATHA $0.36
- Resistance Level
- WKSP $3.90
- ATHA $0.41
- Average True Range (ATR)
- WKSP 0.31
- ATHA 0.03
- MACD
- WKSP -0.03
- ATHA -0.00
- Stochastic Oscillator
- WKSP 28.89
- ATHA 81.60
About WKSP Worksport Ltd.
Worksport Ltd through its subsidiaries, designs, develops, manufactures, and owns the IP on a variety of tonneau covers, solar integrations, and NP (Non-Parasitic), Hydrogen-based true green energy solutions for the sustainable, clean energy, and automotive industries. The company's product includes soft vinyl tonneau covers and hard aluminum tonneau covers. It operates in two reporting segments for financial reporting purposes: Hard Tonneau Covers and Soft Tonneau Covers. Geographically, the company operates in Canada, United States and Other Countries.
About ATHA Athira Pharma Inc.
Athira Pharma Inc is a late clinical-stage biopharmaceutical company focused on developing small molecules engineered to restore neuronal health and slow neurodegeneration. Its pipeline candidates are; Fosgonimeton (ATH-1017) is a small molecule drug candidate designed to enhance the activity of the neurotrophic hepatocyte growth factor (HGF) system; ATH-1020 a novel, orally available, next-generation small molecule drug candidate designed to positively modulate the neurotrophic HGF system; ATH-1105 is a novel, orally available, next-generation, small molecule drug candidate designed to positively modulate the neurotrophic HGF system.